Ernst Timothy S
Officer at BIO
- Sold, on record
- $4.6M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Feb 28, 2024
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BIOBIO-RAD LABORATORIES, INC.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BIOUnusualAug 4, 2021 2021
Sold 327 shares at $760.26 ($249k)
Ernst Timothy S, EVP, General Counsel & Sec
Sold 26.2% of holdings ($947k position)919 shares left0.4x usual sizeFiling
- 2 Form 4 sale BIOUnusualMar 8, 2023 +581 days
Sold 1,746 shares at $486.43 ($849k)
Ernst Timothy S, EVP, General Counsel & Sec
Sold 39.5% of holdings ($2.1M position)2,671 shares leftFiling
- 3 Form 4 sale BIONo planAug 23, 2023 +168 days
Sold 300 shares at $384.69 ($115k)
Ernst Timothy S, EVP, General Counsel & Sec
No 10b5-1 planSold 11% of holdings ($1M position)2,416 shares leftFollows a Form 144Filing
- 4 Form 144 notice BIONoticeAug 23, 2023 same day
Filed to sell 300 shares ($115k)
Ernst Timothy S, Officer
No 10b5-1 planFiling
- 5 Form 144 notice BIONoticeAug 30, 2023 +7 days
Filed to sell 2,350 shares ($924k)
Ernst Timothy S, Officer
No 10b5-1 planFiling
- 6 Form 4 sale BIOUnusualAug 30, 2023 same day
Sold 2,350 shares at $395.60 ($930k)
Ernst Timothy S, EVP, General Counsel & Sec
No 10b5-1 planSold 49.3% of holdings ($1.9M position)2,416 shares leftFollows a Form 144Filing
- 7 Form 144 notice BIONoticeFeb 28, 2024 +182 days
Filed to sell 2,500 shares ($826k)
Ernst Timothy S, Officer
No 10b5-1 plan1.4x usual sizeFiling
- 8 Form 4 sale BIOUnusualFeb 28, 2024 same day
Sold 2,500 shares at $330.55 ($826k)
Ernst Timothy S, EVP, General Counsel & Sec
No 10b5-1 planSold 42.4% of holdings ($1.9M position)3,397 shares left1.4x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | Feb 29, 2024 | BIO | EVP, General Counsel & Sec | Form 4 sale | 2,500 | $826k | 42.4% | Unusual | SEC |
| Feb 28, 2024 | Feb 28, 2024 | BIO | Officer | Form 144 notice | 2,500 | $826k | Notice | SEC | |
| Aug 30, 2023 | Aug 31, 2023 | BIO | EVP, General Counsel & Sec | Form 4 sale | 2,350 | $930k | 49.3% | Unusual | SEC |
| Aug 30, 2023 | Aug 30, 2023 | BIO | Officer | Form 144 notice | 2,350 | $924k | Notice | SEC | |
| Aug 23, 2023 | Aug 23, 2023 | BIO | Officer | Form 144 notice | 300 | $115k | Notice | SEC | |
| Aug 23, 2023 | Aug 23, 2023 | BIO | EVP, General Counsel & Sec | Form 4 sale | 300 | $115k | 11.0% | No plan | SEC |
| Mar 8, 2023 | Mar 8, 2023 | BIO | EVP, General Counsel & Sec | Form 4 sale | 1,746 | $849k | 39.5% | Unusual | SEC |
| Aug 4, 2021 | Aug 5, 2021 | BIO | EVP, General Counsel & Sec | Form 4 sale | 327 | $249k | 26.2% | Unusual | SEC |
| Feb 19, 2021 | Feb 22, 2021 | BIO | EVP, General Counsel & Sec | Form 4 sale | 923 | $592k | 43.1% | Unusual | SEC |
| Dec 4, 2019 | Dec 5, 2019 | BIO | EVP, General Counsel & Sec | Form 4 sale | 1,906 | $705k | 80.7% | Unusual | SEC |
| Aug 14, 2019 | Aug 14, 2019 | BIO | EVP, General Counsel & Sec | Form 4 sale | 310 | $99k | 75.1% | Unusual | SEC |
| May 16, 2019 | May 16, 2019 | BIO | EVP, General Counsel & Sec | Form 4 sale | 846 | $250k | 68.4% | Unusual | SEC |